Continuous clinical improvement of mild‐to‐moderate seborrheic dermatitis and rebalancing of the scalp microbiome using a selenium disulfide–based shampoo after an initial treatment with ketoconazole. (20th August 2021)

• Record Type: Journal Article
• Authors: Massiot, Philippe; Clavaud, Cécile; Thomas, Marie; Ott, Alban; Guéniche, Audrey; Panhard, Ségolène; Muller, Benoît; Michelin, Céline; Kerob, Delphine; Bouloc, Anne; Reygagne, Pascal
• Is Part Of: Journal of cosmetic dermatology. Volume 21:Number 5(2022)
• Page Start: 2215
• Page End: 2225
• Publication Date: 2021-08-20
• Subjects: ketoconazole -- scalp microbiota -- seborrheic dermatitis -- selenium disulfide; Skin -- Diseases -- Treatment -- Periodicals; Lasers in surgery -- Periodicals; Skin -- Pathophysiology -- Periodicals; Surgery, Plastic -- Periodicals; 616.5
• DOI: 10.1111/jocd.14362
• Languages: English
• ISSNs: 1473-2130

Abstract

Abstract: Objective: Scalp seborrheic dermatitis (SD) is a chronic, relapsing, and inflammatory scalp disease. Studies indicate a global bacterial and fungal microbiota shift of scalp SD, as compared to healthy scalp. Ketoconazole and selenium disulfide (SeS2 ) improve clinical signs and symptoms in both scalp dandruff and SD. Aim: The main objective of this study was to investigate the changes in the scalp microbiota diversity and counts in subjects with scalp SD during a two‐phase treatment period. Material and methods: The scalp microbiota and clinical efficacy were investigated in 68 subjects with mild‐to‐moderate scalp SD after an initial one‐month treatment with 2% ketoconazole, and after a 2‐month maintenance phase, either with a 1% SeS2 ‐based shampoo or its vehicle. Results: Thirty one subjects in the active and 37 subjects in the vehicle group participated. Ketoconazole provided an improvement of clinical symptoms (adherent (−1.75 p < 0.05), non‐adherent (−1.5, p < 0.05)) flakes and erythema (scores 1.67–0.93, p < 0.001), in an increased fungal diversity and in a significant ( p < 0.005) decrease of Malassezia spp. SeS2 provided an additional clinical improvement (−0.8; p = 0.0002 and −0.7; p = 0.0081 for adherent and non‐adherent flakes, respectively, at Day 84) compared to the vehicle associated with a low Malassezia spp. count and an additional significant ( p < 0.001) decrease of the Staphylococcus spp. level. Conclusion: Selenium disulfide provides an additional benefit on the scalp microbiota and in clinical symptoms of SD and dandruff after treatment with ketoconazole. The results confirm the role of Staphylococcus spp. in scalp SD and open possible perspectives for preventing relapses.